Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Higher Field Strengths and New Clinical Applications Increase Growth of MRI Systems

By MedImaging staff writers
Posted on 27 Jun 2007
Magnetic resonance imaging (MRI) is one of the most powerful and widely used diagnostic tools by clinicians today. More...
However, there are many challenges such as increasing pricing pressures, regulatory issues, and competition from computed tomography (CT) that need to be overcome in the European MRI systems market, according to a recent marketing report.

Despite these challenges, the market is expected to see growth. The scope for growth is related to the introduction of new applications. The market is not yet saturated and there are a few unexplored niche segments, which offer huge growth potential. Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, found that the European MRI market earned revenues of US$806.5 million in 2006 and estimates this to reach $1.03 billion in 2013.

"The European MRI systems market is primarily driven by the current wide variety of applications and constant development of new ones,” noted Frost & Sullivan research analyst B. Divya. "With continued upgrades in Tesla strength, the number of applications using MRI is increasing from the research point of view and is also becoming increasingly commercially viable.”

With advancements in neurologic, cardiac, and vascular, as well as breast MRI, the market is seeing growth essentially due to the application potential. Each new clinical application increases the usage of MRI systems. Moreover, high-field systems are expected to continue demonstrating strong growth, thereby replacing low-field systems.

However, the current state of the European healthcare system is restraining market growth. In addition, differing reimbursement policies in various geographic regions in the European Union are still another challenge. Furthermore, there is also the inherent challenge arising due to competition from CT.

"The European healthcare industry is experiencing severe financial constraints from having to support an aging population, with contributions from a small portion of working population,” explained Ms. Divya. "Consequently, the governments of various nations are wary of the fact that healthcare spending is exceedingly high, and one of the interesting ways in which nations are reducing healthcare costs is by simply not buying additional equipment.”

As the market is heading toward saturation, market participants will need to concentrate on niche segments. Targeting niche markets can be either through the acquisition of existing small local participants or through the introduction of new products.


Related Links:
Frost & Sullivan

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.